S298: CS585 IS A FIRST-IN-CLASS COMPOUND TARGETING THE IP RECEPTOR FOR PREVENTION OF THROMBOSIS WITHOUT INCREASED RISK OF BLEEDING - S. Lambert; R. Adili; P. Yalavarthi; N. Rhoads; B. Dahlof; A. White; N. Bergh; M. Holinstat (HemaSphere, 2022)